Medulloblastomas, childhood brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of life. Researchers have now published their findings in the journal Nature. They analyzed the genetic changes of each individual cancer cell in tumor samples in order to reconstruct which genetic changes occur first during tumor development and when.

A research team led by PD Dr. Justus Marquet and from the Hertie Institute for Clinical Brain Research has developed two methods that allow muscle activity and training-induced adaptations to be measured completely contactlessly. The studies demonstrate that magnetic fields generated during muscle activity can be captured using highly sensitive quantum sensors - without the need for electrodes or skin contact.

Animal-free testing of chemicals and cosmetics - 07/05/2025

Human reporter skin for visualsing skin reactions

Before new cosmetics can be placed on the market, all ingredients must undergo rigorous testing for safety and efficacy. Dr. Anke Burger-Kentischer of the Fraunhofer IGB has long been at the forefront of animal-free research and has developed an innovative method to quickly and reliably test cosmetics and other chemicals without using animals. She was awarded the 2024 Hamburg Research Prize for her groundbreaking ‘reporter skin’ in vitro model.

This year Furtwangen University (HFU) is launching the “HFU Skills4MedTec” project to further enhance its profile as a leading authority in medical technology and to develop targeted scientific training courses for specialists and managers in the industry.

3D bioprinting is a great hope in the field of regenerative medicine to produce miniaturized tissues and organ precursors with biological functionality. Today, however, scientists are still working on the challenge of producing a printable and at the same time compatible starting material.

New treatment methods: DNA origami-based nanodevices precisely control immune response - 24/04/2025

Bottom-up synthetic immunology for novel therapeutic approaches

Modern therapies for combating cancer and infectious diseases increasingly leverage the body’s own immune system. Several research groups at Heidelberg University are using innovative bottom-up approaches in synthetic immunology to develop new treatment methods that can control the immune response more precisely than previously possible.

Individuals with a genetic predisposition to Alzheimer’s disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms. This is evident in the levels of the protein “beta-synuclein”. An international team report these findings in the journal “Alzheimer’s & Dementia”. The biomarker studied here could potentially help to detect neurodegeneration at an early stage.

The human brain continuously processes sensory impulses that compete for our attention. Our ability to select enables us to process specific information and ignore irrelevant stimuli. In this way, we can recognize a familiar face in a large crowd of people. But how is this made possible?

The “Digital Integration and Innovation in Surgery” project aims to promote the transfer of new findings and research results into practice. The School of Informatics at Reutlingen University will work together with Furtwangen University, BioMedTech e.V., University Hospital Tübingen and other stakeholders to examine how intelligent digital assistance systems can contribute to improved patient care during surgical procedures.

Contact with pets reduces the risk of developing stress-related disorders in adult life in urban children. This is the conclusion of a study conducted by the Section for Molecular Psychosomatic Medicine at Ulm University Hospital together with other researchers from Germany and the USA. Living with animals is said to alleviate inflammatory stress reactions.

Melanie Börries, Professor of Medical Bioinformatics at the Medical Faculty of the University of Freiburg and Director of the Institute of Medical Bioinformatics and Systems Medicine at the Medical Center – University of Freiburg, is being honoured for her pioneering work in personalised cancer therapy.

Baden-Württemberg AI Alliance - 08/04/2025

Achieving widespread use of AI

Artificial intelligence presents both opportunities and risks. The Baden-Württemberg AI Alliance is dedicated to fostering collaboration among AI stakeholders to ensure that AI solutions deliver tangible benefits to citizens and businesses across the state. The alliance will also place greater emphasis on advancing AI applications within the healthcare sector.

The Medical Faculty Heidelberg of Heidelberg University and Mannheim University of Applied Sciences are combining their expertise in infectious disease research, mass spectrometry, and bioinformatics to overcome resistance in malaria vectors. The project is supported by funding from the Gates Foundation.

Metastatic breast cancer requires complex and lengthy treatment, the side effects of which affect the quality of life of patients. These often include sexual problems. In a large international randomized exercise intervention trial, researchers have now shown that women who received a nine-month supervised exercise program reported significantly fewer symptoms than women who did not participate in the training program.

Germany's most important award for young scientists honors the development of immunotherapies against malignant brain tumors.

Researchers from the universities in Konstanz and Vienna discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea. These substances trigger a self-destruction program, which also operates in multi-resistant variants of the pathogen. The novel findings are published in the current issue of Nature Microbiology.

84 percent of Germans consciously consider their diet. For the majority, nutrition is a central topic, but many perceive the public debate as divisive and patronising. According to the latest nutrition study by the Robert Bosch Stiftung and the More in Common, citizens want policies that promote healthy, regional, and affordable food – without regulations or bans. At the same time, they are calling for more say in shaping the food system.

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger RNA – a prerequisite for protein synthesis in the cell. The poorly characterized factors are crucial to ensuring that the molecular machine responsible for splicing is working correctly. A research team has deciphered how the two cellular quality inspectors work.

SpecPlate: an innovative multiwell plate - 26/03/2025

Focus on innovative drug development - accurate, time- and cost-saving

Drug research is a complex and costly process that requires extensive laboratory analyses and vast quantities of consumables, with disposable sample carriers in particular being used in their millions. PHABIOC GmbH has come up with a solution in the form of the SpecPlate, a ground-breaking alternative to sample carriers that reduces the time taken to perform analyses as well as the quantity of materials consumed. Serial production is underway.

Researchers at the German Cancer Research Center (DKFZ) have succeeded in identifying a resistance mechanism that often occurs in a specific targeted therapy against chronic lymphocytic leukemia (CLL). The drug ibrutinib is effective in many cases, but therapy resistance often develops during the course of treatment. In cell culture experiments and in mice, the resistance mechanism was successfully overcome using a second drug.

A recent article by Prof. Dr. Martin Haimerl and Prof. Dr. Christoph Reich of Furtwangen University shows that machine learning (ML) in medicine is often evaluated without a comprehensive risk assessment. The authors investigated the extent to which current scientific papers include risk-based metrics in the evaluation of AI models for medical devices.

Using artificial intelligence to revolutionize drug development is the aim of the start-up "EmbryoNet AI Technologies" led by Konstanz biologist Patrick Müller. Müller and his team have now been awarded the start-up prize by the Federal Ministry for Economic Affairs and Climate Action (BMWK) for their business concept.

Stomach ulcers, gastritis and even stomach cancer are often the result of an infection with Helicobacter pylori. If the bacterium remains unrecognised for a long time, this can have serious consequences. Researchers have now developed a miniaturisable sensor system for the mobile analysis of breath that is effective, fast and inexpensive. The research team uses a biological survival trick of the stomach germ to detect the bacterium.

The weight of expectant mothers could play a role in the development of acute lymphoblastic leukemia (ALL) in daughters – but not in sons. This has been shown by researchers at the German Cancer Research Center (DKFZ).

Researchers have developed a promising cellular immunotherapy for the treatment of glioblastomas: They equipped T cells with a receptor that recognizes a protein of the brain tumors that is responsible for the dangerous stem cell properties. The therapeutic T cells directed against this target structure were able to specifically destroy human brain tumors in laboratory experiments and in mice.

Scientists at the Max Planck Institute for Intelligent Systems developed a single-cell green microalgae coated with magnetic material. This miniature robot was put to the test: would the microalgae with its magnetic coating be able to swim through narrow spaces and, additionally, in a viscous fluid that mimics those found in the human body? Would the tiny robot be able to fight its way through these difficult conditions?

With the goal of creating living cells from non-living components, scientists in the field of synthetic biology work with RNA origami. This tool uses RNA biomolecule to fold new building blocks, making protein synthesis superfluous. In pursuit of the artificial cell, a research team has cleared a crucial hurdle. Using the new RNA origami technique, they succeeded in producing nanotubes that fold into cytoskeleton-like structures.

University of Tübingen research team shortens the search for attackers that can wipe out multiresistant pathogens – with the aim of treating infections without antibiotics

The Max Planck Society and the Dieter Schwarz Foundation (DSS) have embarked on a groundbreaking initiative. On March 13, 2025, they signed an agreement through which the foundation will support an innovative approach by the Max Planck Institute for Medical Research in Heidelberg to translate basic research findings into practical applications. As part of this endeavour, two new departments of the institute will be established in Heilbronn.

Microorganisms produce nutrients in bioreactors - 12/03/2025

CO2 and H2 as starting materials for proteins and vitamins

Agricultural land needed to sustain the world's growing population is becoming increasingly scarce. To help address this challenge, researchers from the Environmental Biotechnology Group at the University of Tübingen have developed an innovative and sustainable power-to-vitamin technology. This breakthrough enables protein- and vitamin-rich foods to be produced with the help of microorganisms in a bioreactor using carbon dioxide and…

Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions have hardly been studied to date. Researchers from the German Cancer Research Center, the Mannheim Medical Faculty and Columbia University have now published that hepatic stellate cells control liver metabolism as well as liver regeneration and size. The results of the study could contribute to new therapeutic approaches for liver diseases.

Donating blood saves lives – but what long-term effects does this practice have on our bodies? Researchers from the German Cancer Research Center (DKFZ), the HI-STEM stem cell institute* and the German Red Cross Blood Donor Service, among others, have now discovered that frequent blood donations cause genetic adaptations in blood stem cells that promote the regeneration of blood cells.

Researchers have developed a new method that enables a more precise analysis of individual tumor cells circulating in the blood. This allows not only the previously possible genomic investigation of such tumor cells, but also the focused analysis of single-cell signaling pathways at the functional protein level. The combined analysis of the mutated genome and signaling proteins opens up new avenues for more targeted treatment methods.

A recent study by the Hector Institute for Translational Brain Research at the CIMH provides the first cellular insights into how psilocin promotes the growth and networking of human nerve cells.

Scientists at the Max Planck Institute for Intelligent Systems, the University of Tübingen and the University of Stuttgart under the Bionic Intelligence Tübingen Stuttgart (BITS) collaboration developed a biorobotic arm that can mirror human tremors. Artificial muscles on either side of the forearm contract and relax to suppress the involuntary shaking of the wrist and hand.

This year, the Brain Prize worth more than one million euros, honors pioneering work on nervous system-cancer interactions: Neurologist Frank Winkler, who researches at the Heidelberg University and at the German Cancer Research Center and treats patients with brain tumors at the Heidelberg University Hospital, discovered that nerve cells in the brain communicate with brain tumor cells. This causes the disease to progress.

People with metabolic dysfunction-associated steatotic liver disease (MASLD) and more so with metabolic dysfunction-associated steatohepatitis and MASLD-associated hepatic fibrosis can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 diabetes, cardiovascular and chronic kidney disease, and cancers. Future research might be beneficial for implementing precision medicine in MASLD.

Using a new combination of three sensors and artificial intelligence, researchers at Heidelberg Medical Faculty of Heidelberg University and Heidelberg University Hospital are recognising patterns in babies' movements that show whether their nervous system is developing healthily.

The Bayer Foundation's Early Excellence in Science Award 2024 in the category of Data Science goes to Ivana Winkler of the German Cancer Research Center (DKFZ). Winkler's work uncovered the unexpected effect of female reproductive capacity: the constantly recurring remodeling of the organs of the female reproductive tract during the sexual cycle leads to fibrosis and chronic inflammation over the years.

A research team including scientists from Heidelberg University Hospital has gained new insights into HIV-1. Researchers have discovered the mechanism behind an important step in the life cycle of HIV. Working together with teams at Heidelberg and Yale Universities, they found that the enigmatic “spacer peptide 2”, one of the virus components, plays a key role in converting immature HIV-1 particles into infectious particles.

Targeted molecular interventions in the replication cycle and the immune recognition of viruses are intended to prevent viral entry into cells and virus replication. Scientists work on new approaches to combating highly dangerous viral diseases such as yellow fever or Lassa fever. The European Union is supporting the project over a period of five years to the tune of just under eight million euros.

Zebrafish can completely replace damaged heart muscle cells: The affected organ becomes fully functional again. Researchers at Ulm University have discovered that a specific cell-to-cell communication signal helps them to cope better with replication stress. This stress inhibits tissue regeneration in humans and mammals as they age. In Zebrafish a signalling protein ensures that the cells of the damaged organ continue to divide and thus multiply.

A protein with contradictory properties: Despite its large negative surface charge, it has a strong tendency to take up electrons, which are also negatively charged. The researchers discovered positively charged calcium ions inside the protein very near the electrons, counteracting their charge. They see this as a natural way of handling opposing electrical charges and allowing the protein to optimally fulfill its biological function.

Controllable microcatheters - 20/02/2025

Robot-assisted control of surgical instruments using magnetic resonance imaging

Catheter-based examinations and surgical procedures are severely limited by the restricted controllability of conventional instruments and harmful radiation exposure to both patients and medical staff caused by prolonged exposure to radiation during fluoroscopy. EndoSurge, a Stuttgart-based start-up, has developed innovative robotic microcatheters that can be precisely controlled using the magnetic field of an MRI device.

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)*. The team discovered that the tumor reprograms the neurons for its own benefit.

A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great importance for cancer medicine because a change of identity of cells has come into focus as a fundamental principle of carcinogenesis for several years. The research team was able to show that the newly discovered guardian is so powerful that it can slow down highly potent cancer drivers and cause malignant liver tumors to regress in mice.

Researchers of the Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical Studies (HITS) have developed a synthetic peptide based on the natural protein S100A1, a nearly universal “fuel” for weakened hearts. The researchers combined computer-aided methods with lab studies to investigate the therapeutic effect of the so called S100A1ct peptide molecule.

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as closely as possible. Drug tests in this model were found to correlate very well with actual patient responses, making it a valuable method for investigating therapies.

In collaboration with Heraeus, the German Institutes of Textile and Fiber Research (DITF) are developing fibers and textiles with a novel infection protection system. The basis is an antimicrobial mechanism of action licensed from Heraeus and marketed under the name AGXX. The goal of the collaboration is to optimally integrate the AGXX technology into textile finishes and coatings and to incorporate it into fiber-spinnable polymers.

The spliceosome, ensures that the genetic information from the genome, after being transcribed into mRNA precursors, is correctly assembled into mature mRNA. Splicing is a basic requirement for producing proteins. Researchers at the Heidelberg University Biochemistry Center (BZH) have succeeded for the first time in depicting a faultily “blocked” spliceosome at high resolution and reconstructing how it is recognized and eliminated in the cell.

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center, the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center has discovered new details about the spread of the incurable bone marrow cancer multiple myeloma in the body: When the cancer cells break out of the bone and multiply outside the bone marrow, a wide variety of tumor cells arise, accompanied by a significantly altered immune response.

Project REVeyeVE - 06/02/2025

Targeted, virus-free gene therapy for the eye using degradable nanopropellers

Eye diseases that result in blindness in young people are primarily caused by genetic mutations. An interdisciplinary team of researchers from the Universities of Tübingen and Heidelberg is developing an innovative gene therapy method using biodegradable, magnetic nanopropellers. These innovative nanopropellers can effectively deliver intact genes into the affected cells, offering a potential solution for treating genetic disorders of this kind.